Supporting female founder initiatives across the UK & Ireland

Find out more  
← Back to portfolio Porfolio / OrganOx

OrganOx

British MedTech business

Company overview

OrganOx metra is the world’s first fully automated system for keeping a human donor liver functioning for up to 24 hours outside the body.

The underpinning technology was developed at the University of Oxford and OrganOx Ltd was spun out from the University in 2008 to develop and manufacture the system.

Website
organox.com

Company information

Head office
  • Oxford
CEO
  • Craig Marshall
BGF office
Investment date
  • Jan 2020
Total BGF investment
  • £4.6 million